Dalziel, K., Segal, L., & Mortimer, D. (2008). Review of Australian health economic evaluation – 245 interventions: What can we say about cost effectiveness? Cost Effectiveness and Resource Allocation, 6(1), 9.
Article PubMed PubMed Central Google Scholar
Collado-Mateo, D., Chen, G., Garcia-Gordillo, M. A., Iezzi, A., Adsuar, J. C., Olivares, P. R., & Gusi, N. (2017). Fibromyalgia and quality of life: Mapping the revised fibromyalgia impact questionnaire to the preference-based instruments. Health and Quality of Life Outcomes, 15(1), 114.
Article PubMed PubMed Central Google Scholar
Prieto, L., & Sacristán, J. A. (2003). Problems and solutions in calculating quality-adjusted life years (QALYs). Health and Quality of Life Outcomes, 1, 80.
Article PubMed PubMed Central Google Scholar
Richardson, J., Iezzi, A., & Khan, M. A. (2015). Why do multi-attribute utility instruments produce different utilities: The relative importance of the descriptive systems, scale and ‘micro-utility’ effects. Quality of life Research: An International Journal of Quality of life Aspects of Treatment care and Rehabilitation, 24(8), 2045–2053.
Wells, G. A., Russell, A. S., Haraoui, B., Bissonnette, R., & Ware, C. F. (2011). Validity of quality of Life Measurement Tools — from generic to Disease-specific. The Journal of Rheumatology, 88, 2.
Ware, J. E. Jr., Gandek, B., Guyer, R., & Deng, N. (2016). Standardizing disease-specific quality of life measures across multiple chronic conditions: Development and initial evaluation of the QOL Disease Impact Scale (QDIS®). Health and Quality of Life Outcomes, 14, 84.
Article PubMed PubMed Central Google Scholar
Kularatna, S., Byrnes, J., Chan, Y. K., Carrington, M. J., Stewart, S., & Scuffham, P. A. (2017). Comparison of contemporaneous responses for EQ-5D-3L and Minnesota living with Heart Failure; a case for disease specific multiattribute utility instrument in cardiovascular conditions. International Journal of Cardiology, 227, 172–176.
Cichosz, S. L., Ehlers, L. H., & Hejlesen, O. (2016). Health effectiveness and cost-effectiveness of telehealthcare for heart failure: Study protocol for a randomized controlled trial. Trials, 17(1), 1–6.
Kularatna, S., Chen, G., Senanayake, S., Hettiarachchi, R., Parsonage, W., Norman, R., et al. (2022). Australian Health Utility Value set for MacNew-7D heart disease-specific measure. Heart Lung and Circulation, 31, S71.
Kularatna, S., Rowen, D., Mukuria, C., McPhail, S., Chen, G., Mulhern, B., et al. (2022). Development of a preference-based heart disease-specific health state classification system using MacNew heart disease-related quality of life instrument. Quality of Life Research, 31(1), 257–268.
World Health Organization. Cardiovascular diseases (CVDs) - Key Facts: WHO (2021). [ https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
Chen, G., Garcia-Gordillo, M. A., Collado-Mateo, D., del Pozo-Cruz, B., Adsuar, J. C., Cordero-Ferrera, J. M., et al. (2018). Converting Parkinson-Specific scores into Health State Utilities to assess cost-utility analysis. The Patient - Patient-Centered Outcomes Research, 11(6), 665–675.
Chen, G., McKie, J., Khan, M. A., & Richardson, J. R. (2015). Deriving health utilities from the macnew heart disease quality of life questionnaire. European Journal of Cardiovascular Nursing, 14(5), 405–415.
Kularatna, S., Senanayake, S., Chen, G., & Parsonage, W. (2020). Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure. Health and Quality of Life Outcomes, 18(1), 1–12.
Green, C. P., Dennis, C. B. P., Bresnahan, R., & Spertus, J. A. (2000). Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: A new health status measure for heart failure. Journal of the American College of Cardiology, 35(5), 1245–1255.
Article CAS PubMed Google Scholar
Spertus, J. A., Jones, P. G., Sandhu, A. T., & Arnold, S. V. (2020). Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art review. Journal of the American College of Cardiology, 76(20), 2379–2390.
Bilbao, A., Escobar, A., García-Perez, L., Navarro, G., & Quirós, R. (2016). The Minnesota living with heart failure questionnaire: Comparison of different factor structures. Health and Quality of Life Outcomes, 14, 23.
Article PubMed PubMed Central Google Scholar
Thomas, M., Jones, P. G., Arnold, S. V., & Spertus, J. A. (2021). Interpretation of the Seattle Angina Questionnaire as an Outcome measure in clinical trials and clinical care: A review. JAMA Cardiology, 6(5), 593–599.
Article PubMed PubMed Central Google Scholar
Kularatna, S., Senanayake, S., Chen, G., & Parsonage, W. (2020). Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure. Health and Quality of Life Outcomes, 18(1), 115.
Article PubMed PubMed Central Google Scholar
Statistics CiRaMfO Root mean square error (RMSE) 2019 [ https://ec.europa.eu/eurostat/cros/content/root-mean-square-error-rmse_en#:~:text=The%20Root%20mean%20square%20erro,of%20variance%20and%20squared%20Bias.
Neilson, A. R., Jones, G. T., Macfarlane, G. J., Pathan, E. M., McNamee, P., & Generating (2022). EQ-5D-5L health utility scores from BASDAI and BASFI: A mapping study in patients with axial spondyloarthritis using longitudinal UK registry data. The European Journal of Health Economics, 23(8), 1357–1369.
Article PubMed PubMed Central Google Scholar
Brazier, J. E., Yang, Y., Tsuchiya, A., & Rowen, D. L. (2010). A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. The European Journal of Health Economics, 11, 215–225.
Meregaglia, M., Whittal, A., Nicod, E., & Drummond, M. (2020). Mapping’ Health State Utility values from non-preference-based measures: A systematic literature. Review in Rare Diseases PharmacoEconomics, 38(6), 557–574.
Brazier, J., Czoski-Murray, C., Roberts, J., Brown, M., Symonds, T., & Kelleher, C. (2008). Estimation of a preference-based index from a condition-specific measure: The King’s Health Questionnaire. Medical Decision Making, 28(1), 113–126.
Yang, F., Devlin, N., & Luo, N. (2019). Impact of mapped EQ-5D utilities on cost-effectiveness analysis: In the case of dialysis treatments. The European Journal of Health Economics, 20, 99–105.
Youngerman, B. E., Mahajan, U. V., Dyster, T. G., Srinivasan, S., Halpern, C. H., McKhann, G. M., & Sheth, S. A. (2021). Cost-effectiveness analysis of responsive neurostimulation for drug‐resistant focal onset epilepsy. Epilepsia, 62(11), 2804–2813.
Trenaman, L., Stacey, D., Bryan, S., Taljaard, M., Hawker, G., Dervin, G., et al. (2017). Decision aids for patients considering total joint replacement: A cost-effectiveness analysis alongside a randomised controlled trial. Osteoarthritis and Cartilage, 25(10), 1615–1622.
Article CAS PubMed Google Scholar
King, R. D., Orhobor, O. I., & Taylor, C. C. (2021). Cross-validation is safe to use. Nature Machine Intelligence, 3(4), 276.
Schaffer, C. (1993). Selecting a classification method by cross-validation. Machine Learning, 13, 135–143.
Valsamis, E. M., Beard, D., Carr, A., Collins, G. S., Brealey, S., Rangan, A., et al. (2023). Mapping the Oxford shoulder score onto the EQ-5D utility index. Quality of life Research, 32(2), 507–518.
Doble, B., & Lorgelly, P. (2016). Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: Assessing the external validity of existing mapping algorithms. Quality of Life Research, 25, 891–911.
Ali, F. M., Kay, R., Finlay, A. Y., Piguet, V., Kupfer, J., Dalgard, F., & Salek, M. S. (2017). Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression. Quality of Life Research, 26, 3025–3034.
Article PubMed PubMed Central Google Scholar
Klapproth, C. P., van Bebber, J., Berlin, C. U., Gibbons, C. J., Valderas, J. M., Alain, L. (2020). Predicting EQ-5D Index Scores from the PROMIS-29 Pro le for the United Kingdom, France, and Germany.
Austin, D. E., Lee, D. S., Wang, C. X., Ma, S., Wang, X., Porter, J., & Wang, B. (2022). Comparison of machine learning and the regression-based EHMRG model for predicting early mortality in acute heart failure. International Journal of Cardiology, 365, 78–84.
Mortazavi, B. J., Downing, N. S., Bucholz, E. M., Dharmarajan, K., Manhapra, A., Li, S-X., et al. (2016). Analysis of machine learning techniques for heart failure readmissions. Circulation: Cardiovascular Quality and Outcomes, 9(6), 629–640.
留言 (0)